These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Relationship between chronic stress-related neural activity, physiological dysregulation and coronary artery disease in psoriasis: Findings from a longitudinal observational cohort study. Lateef SS; Al Najafi M; Dey AK; Batool M; Abdelrahman KM; Uceda DE; Reddy AS; Svirydava MD; Nanda N; Ortiz JE; Prakash N; Rodante JA; Keel A; Zhou W; Chen MY; Playford MP; Teague HL; Tawakol AA; Gelfand JM; Powell-Wiley TM; Mehta NN Atherosclerosis; 2020 Oct; 310():37-44. PubMed ID: 32882485 [TBL] [Abstract][Full Text] [Related]
15. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535 [TBL] [Abstract][Full Text] [Related]
16. Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance. Martin SS; Qasim AN; Wolfe M; St Clair C; Schwartz S; Iqbal N; Schutta M; Bagheri R; Mehta NN; Rader DJ; Reilly MP Am J Cardiol; 2011 Feb; 107(3):393-8. PubMed ID: 21257004 [TBL] [Abstract][Full Text] [Related]
17. Application of machine learning to determine top predictors of noncalcified coronary burden in psoriasis: An observational cohort study. Munger E; Choi H; Dey AK; Elnabawi YA; Groenendyk JW; Rodante J; Keel A; Aksentijevich M; Reddy AS; Khalil N; Argueta-Amaya J; Playford MP; Erb-Alvarez J; Tian X; Wu C; Gudjonsson JE; Tsoi LC; Jafri MS; Sandfort V; Chen MY; Shah SJ; Bluemke DA; Lockshin B; Hasan A; Gelfand JM; Mehta NN J Am Acad Dermatol; 2020 Dec; 83(6):1647-1653. PubMed ID: 31678339 [TBL] [Abstract][Full Text] [Related]
18. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients. Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733 [TBL] [Abstract][Full Text] [Related]
19. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice. Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029 [TBL] [Abstract][Full Text] [Related]
20. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study. van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]